Want to see USNA full AI Analyst Report?
USNA Stock Chart & Stats
$22.17
-$0.14(-0.63%)
At close: 4:00 PM EDT
$22.17
-$0.14(-0.63%)
Day’s Range― - ―
52-Week Range$16.60 - $32.32
Previous Close$22.67
Volume32.73K
Average Volume (3M)173.43K
Market Cap
$408.22M
Enterprise Value$213.63
Total Cash (Recent Filing)$162.75M
Total Debt (Recent Filing)$14.00M
Price to Earnings (P/E)46.7
Beta1.12
Next Earnings
Aug 04, 2026EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding18,463,010
10 Day Avg. Volume170,208
30 Day Avg. Volume173,431
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.12
Revenue Forecast (FY)$938.74M
Bulls Say, Bears Say
Bulls Say
Very High Gross MarginsSustained ~77% gross margin reflects durable product-level economics in supplements and personal care. High gross margins provide structural cushion for SG&A, support reinvestment in R&D and retail rollouts, and allow margin recovery to drive profit as volumes normalize.
Conservative, Low-leverage Balance SheetExtremely low leverage gives the company long-term financial flexibility to fund omni-channel expansion, absorb working-capital swings from retail inventory builds, and withstand macro shocks without pressured refinancing or forced asset sales.
Omni-channel Growth And Retail Traction (Rise Wellness)Rapid retail scale and a planned >20% omni-channel mix represent a structural distribution shift away from single-channel dependence. National retailer rollouts and subscription traction diversify revenue sources, improve visibility for repeat purchases, and can materially expand addressable market over time.
Bears Say
Compressed Profitability (low Net Margin)A ~1% trailing net margin is materially below historical levels and limits the company's ability to convert revenue into durable earnings. Persistent margin compression reduces funds for capex, marketing, and shareholder returns unless structural cost efficiencies or sustained revenue mix improvements occur.
Weak Cash Generation And Low Free Cash FlowVery low FCF constrains the firm’s capacity to self-fund retail inventory, marketing, or manufacturing integrations without tapping reserves or altering capital allocation. Poor cash conversion increases vulnerability to execution slippage and reduces optionality for strategic investments.
HYA Marketing/SG&A Pressure And Inventory Cash UseElevated customer-acquisition costs and higher SG&A for HYA, plus meaningful cash deployed to seed retail inventory, prolong the brand's path to profitability. These structural burn elements can depress margins and cashflow for multiple quarters until acquisition economics and retailer cadence stabilize.
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $16.60 and its highest was $32.32 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $408.22M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Aug 04, 2026 which is tomorrow.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on May 05, 2026. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.17.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.43.
How many shares outstanding does USANA Health have?
USANA Health has 18,463,010 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of $0.61 in its last earnings report, beating expectations of $0.44. Following the earnings report the stock price went up 3.894%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
USNA Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 32.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $619.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful progress across multiple strategic priorities: sequential recovery in the core nutritional business, strong acceleration and retail traction for Rise Wellness, and international and retail expansion for HYA alongside operational integrations and a sizable R&D pipeline. Near-term pressures include higher customer acquisition costs (HYA), increased SG&A, cash used to support initial retail inventory (Costco), and some uncertainty around retailer cadence and macro risks. On balance, the positive operational momentum, reaffirmed guidance ($925M–$1.0B) and advancing omni-channel mix outweigh the contained near-term costs and risks.View all USNA earnings summariesTechnical Analysis
Ownership Overview
40.78% Insiders
10.58% Mutual Funds
0.40% Other Institutional Investors
36.26% Public Companies and
Individual Investors